Evidence map›Paper›PMID 36234779›Full record

ArticleMolecules (Basel, Switzerland)2022

Evaluation of the Anti-Cancer Potential of

Hadeer Darwish, Sarah Alharthi, Radwa A Mehanna, Samar S Ibrahim, Mustafa A Fawzy, Saqer S Alotaibi, Sarah M Albogami, Bander Albogami, Sedky H A Hassan, Ahmed Noureldeen

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Hadeer DarwishDepartment of Biotechnology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Sarah AlharthiDepartment of Chemistry, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Radwa A MehannaDepartment of Physiology, Faculty of Medicine, Alexandria University, Alexandria P.O. 21544, Egypt.ORCID 0000-0001-9048-4464
Samar S IbrahimCenter of Excellence for Research in Regenerative Medicine and Applications (CERRMA), Faculty of Medicine, Alexandria University, Alexandria P.O. 21544, Egypt.
Mustafa A FawzyDepartment of Biology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0002-5618-2208
Saqer S AlotaibiDepartment of Biotechnology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0002-6162-7953
Sarah M AlbogamiDepartment of Biotechnology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0003-0774-5550
Bander AlbogamiDepartment of Biology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0002-2592-8281
Sedky H A HassanDepartment of Biology, College of Science, Sultan Qaboos University, P.O. Box 36, Muscat 123, Oman.ORCID 0000-0003-2481-5231
Ahmed NoureldeenDepartment of Biology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0003-3890-4032
Taif University · SAAlexandria University · EGSultan Qaboos University · OM

Funding

The Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia ‎1-441-123‎
6 · The paper itself

Abstract

Chemotherapy is an aggressive form of chemical drug therapy aiming to destroy cancer cells. Adjuvant therapy may reduce hazards of chemotherapy and help in destroying these cells when obtained from natural products, such as medical plants. In this study, the potential therapeutic effect of

Indexed as

AdenocarcinomaColorectal NeoplasmsRosaAscorbic AcidCaco-2 CellsCitric AcidHumansKi-67 AntigenPlant ExtractsVitaminsAscorbic AcidCitric AcidKi-67 AntigenPlant ExtractsVitaminsanti-cancer activitybio-elicitorscallus inductioncolorectal cancer cell lineRosa damascena

Identifiers

PMID36234779
PMCPMC9572977
OpenAlexW4296993880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.